What is the recommended dosage for Macrobid (nitrofurantoin) for uncomplicated urinary tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosage for Macrobid (Nitrofurantoin) for Uncomplicated UTIs

The recommended dosage for Macrobid (nitrofurantoin monohydrate/macrocrystals) for uncomplicated urinary tract infections is 100 mg twice daily for 5 days. 1, 2

Standard Dosing Regimens

  • Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg twice daily for 5 days is the first-line regimen recommended by the Infectious Diseases Society of America (IDSA) and the European Society for Microbiology and Infectious Diseases 1, 2
  • Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5 days is an alternative formulation 1
  • Nitrofurantoin macrocrystals prolonged release: 100 mg twice daily for 5 days 1

Efficacy and Supporting Evidence

  • Nitrofurantoin is recommended as a first-line agent due to minimal resistance and limited propensity for collateral damage 1, 2
  • Clinical cure rates with nitrofurantoin range from 88-93% for uncomplicated UTIs in women 2, 3
  • Bacterial cure rates range from 81-92% for uncomplicated UTIs 2, 3
  • The 5-day regimen of nitrofurantoin has been shown to be equivalent to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in clinical and microbiological cure rates 2

Special Considerations

Renal Function

  • Nitrofurantoin is contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased risk of toxicity 4
  • For patients with reduced renal function, alternative agents such as trimethoprim-sulfamethoxazole or fosfomycin trometamol should be considered 4

Duration of Treatment

  • While UK guidelines sometimes recommend 3-day courses, most international guidelines including the IDSA recommend 5-day courses 1, 2, 5
  • The European Association of Urology specifically lists 5 days as the recommended duration 1
  • There is limited direct evidence supporting 3-day courses of nitrofurantoin, unlike other antibiotics where shorter courses may be effective 5

Alternative Regimens for Specific Situations

  • For VRE (Vancomycin-resistant Enterococci) uncomplicated UTIs: 100 mg four times daily is recommended 1, 2
  • For men with UTIs: Limited observational studies support 7-14 days of therapy rather than the 5-day regimen used for women 6

Common Side Effects

  • Nausea and headache are the most commonly reported side effects 2
  • Adverse event rates range from 5.6-34% across studies 2

Monitoring

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1
  • For women whose symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture and antimicrobial susceptibility testing should be performed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.